Similarly, ORFV NA1/11 treatment also efficiently inhibited the growth of implanted lung cancer and increased the levels of cleavage caspase 3 expression in the tumor tissues, indicating that ORFV NA1/11 treatment promoted lung cancer cell apoptosis in the tumors. This evidence concerns the gene CASP3 and lung carcinoma.